Méndez Lucía, Ferreira Jorge, Caneiras Cátia
Microbiology Research Laboratory on Environmental Health (EnviHealthMicro Lab), Institute of Environmental Health (ISAMB), Faculty of Medicine, Universidade de Lisboa, 1649-028 Lisboa, Portugal.
Pulmonology Department, Centro Hospitalar Entre o Douro e Vouga, 4520-221 Santa Maria da feira, Portugal.
Microorganisms. 2021 Nov 17;9(11):2369. doi: 10.3390/microorganisms9112369.
Herein, we describe a case report of a critically ill patient, a 48-year-old man without comorbidities admitted to the hospital with a serious type 1 (hypoxemic) respiratory insufficiency and confirmed diagnosis of COVID-19. After 5 days with invasive mechanical ventilation, the patient developed a bacterial co-infection, namely a pneumonia by , requiring the last line of respiratory support: extracorporeal membrane oxygenation (ECMO). Subsequently, his clinical situation gradually stabilized, until he was discharged from the hospital on day 61, being accompanied in ambulatory consultation by the physical medicine and pulmonology department during the post-COVID-19 recovery. is a Gram-negative bacterium that is rarely isolated from human specimens and is rarely considered to be pathogenic. However, COVID-19 disease can cause substantial organ dysfunction and can be associated with bacterial secondary infections which can favor the emergence of rare infectious diseases by uncommon microorganisms.
在此，我们描述一例危重症患者的病例报告，该患者为一名48岁男性，无合并症，因严重的1型（低氧血症型）呼吸功能不全入院，并确诊感染新型冠状病毒肺炎（COVID-19）。在进行有创机械通气5天后，患者发生了细菌合并感染，即由[细菌名称未给出]引起的肺炎，需要进行最后一线呼吸支持：体外膜肺氧合（ECMO）。随后，他的临床状况逐渐稳定，直到第61天出院，在COVID-19康复后的门诊咨询中，由物理医学和肺病科陪同。[细菌名称未给出]是一种革兰氏阴性菌，很少从人类标本中分离出来，很少被认为具有致病性。然而，COVID-19疾病可导致严重的器官功能障碍，并可能与细菌继发感染相关，这可能有利于罕见微生物引发罕见传染病。
